Match!

DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER

Published on Jan 1, 2020in Endocrine Practice4.149
· DOI :10.4158/EP-2019-0182
Antonio Matrone7
Estimated H-index: 7
,
Carla Gambale1
Estimated H-index: 1
+ 10 AuthorsRossella Elisei66
Estimated H-index: 66
Abstract
Abstract Objective: In intermediate risk DTC (IR-DTC) patients, selective use of radioiodine (131-I) for remnant ablation and/or as adjuvant therapy (RRA) is advocated. The recently suggested post-...
  • References (0)
  • Citations (0)
References0
Newest
Cited By0
Newest